Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Categories for... News

News

New platform set to accelerate early-stage targeted protein degradation

READ ARTICLE

News

Sygnature Discovery completes acquisition of SB Drug Discovery to further strengthen its market-leading capabilities

READ ARTICLE

News

Sygnature Discovery partners the Oncology Development Programme (ODP2) to find UK-based breakthroughs in Oncology

READ ARTICLE

News

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

READ ARTICLE

News

Sygnature Discovery acquires Peak Proteins

READ ARTICLE

News

Paper on drug discovery equipment

READ ARTICLE

News

500 – and counting!

READ ARTICLE

News

Taking a 3D view of heart failure with River BioMedics

READ ARTICLE

News

Our new Chairman: Dr Charles Woler

READ ARTICLE

News

Sygnature strengthens with MedChemica software solution

READ ARTICLE

News

Expansions, transactions and all action: Our 2021 recap!

READ ARTICLE

News

New CFO Jordison steps up

READ ARTICLE